Register entry

Gyeongbuk Institute of IT Convergence Industry Technology

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
0
Countries
1
Base
South Korea
Authorisation

Registered operations

Labelling1Finished drug manufacture1Packaging1Relabelling1Repackaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Gyeongbuk Institute of IT Convergence Industry Technology25 Gongdan 9-ro 12-gil, Jillyang-eup, Gyeongsan, Gyeongsangbuk-do 38463, Korea, South (KOR)Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging3033279948688452435
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
Bephor Reviving Suncream SPF50Ethylhexyl Methoxycinnamate, Homosalate, Zinc Oxidelotion, topical87591-001OTC MONOGRAPH DRUG
Compare

Comparable companies in South Korea

Enquiry

Common questions

Is Gyeongbuk Institute of IT Convergence Industry Technology FDA approved?
Gyeongbuk Institute of IT Convergence Industry Technology holds 1 FDA-registered establishment in South Korea. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Gyeongbuk Institute of IT Convergence Industry Technology's drugs manufactured?
The FDA register lists Gyeongsangbuk-do 38463. Registered operations: labelling, finished drug manufacture, packaging, relabelling, repackaging.
What drugs does Gyeongbuk Institute of IT Convergence Industry Technology make?
1 product is listed under Gyeongbuk Institute of IT Convergence Industry Technology in the openFDA NDC Directory, most often as lotion. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.